Gaush Meditech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,380	1,428	1,406	1,254	1,298
Revenue Growth (YoY)	-3.36%	1.58%	12.16%	-3.42%	34.94%
Cost of Revenue	747.16	774.43	721.64	632.54	696.61
Gross Profit	633.2	653.96	684.6	621.25	601.61
Selling, General & Admin	418.98	378.36	378.21	333.94	320.99
Research & Development	92.58	78.42	52.88	41.09	23.51
Other Operating Expenses	17.75	31.61	0.2	19.19	13.8
Operating Expenses	529.3	488.39	431.3	394.21	358.3
Operating Income	103.9	165.58	253.3	227.03	243.32
Interest Expense	-19.59	-36.71	-50.61	-42.68	-83.53
Interest & Investment Income	-	3.18	6.58	4.68	2.02
Currency Exchange Gain (Loss)	-	-	15.56	-172.47	61.82
Other Non Operating Income (Expenses)	30.37	19.52	18.8	16.43	13.97
EBT Excluding Unusual Items	114.68	151.56	243.63	32.99	237.6
Gain (Loss) on Sale of Investments	-	3.72	3.96	-307.42	-375.51
Gain (Loss) on Sale of Assets	-	-	0.15	-0.67	-0.05
Pretax Income	114.68	155.29	247.74	-275.09	-137.96
Income Tax Expense	23.49	66.76	74.82	77.62	53.61
Earnings From Continuing Operations	91.19	88.52	172.91	-352.71	-191.57
Minority Interest in Earnings	5	3.87	0.61	3.09	1.12
Net Income	96.19	92.39	173.52	-349.62	-190.45
Net Income to Common	96.19	92.39	173.52	-349.62	-190.45
Net Income Growth	4.11%	-46.75%	-	-	-
Shares Outstanding (Basic)	146	148	148	97	96
Shares Outstanding (Diluted)	146	148	148	97	96
Shares Change (YoY)	-1.41%	-0.14%	52.69%	1.16%	-9.03%
EPS (Basic)	0.66	0.63	1.17	-3.61	-1.99
EPS (Diluted)	0.66	0.63	1.17	-3.61	-1.99
EPS Growth	5.59%	-46.68%	-	-	-
Free Cash Flow	-	93.12	214.11	189.03	137.94
Free Cash Flow Per Share	-	0.63	1.45	1.95	1.44
Dividend Per Share	-	0.282	0.998	-	-
Dividend Growth	-	-71.77%	-	-	-
Gross Margin	45.87%	45.78%	48.68%	49.55%	46.34%
Operating Margin	7.53%	11.59%	18.01%	18.11%	18.74%
Profit Margin	6.97%	6.47%	12.34%	-27.88%	-14.67%
Free Cash Flow Margin	-	6.52%	15.23%	15.08%	10.63%
EBITDA	161	222.68	306.06	271.91	287.2
EBITDA Margin	11.66%	15.59%	21.77%	21.69%	22.12%
D&A For EBITDA	57.1	57.1	52.76	44.87	43.88
EBIT	103.9	165.58	253.3	227.03	243.32
EBIT Margin	7.53%	11.59%	18.01%	18.11%	18.74%
Effective Tax Rate	20.48%	42.99%	30.20%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.